Davidson J - Search Results

1

Swinnen and DeVries: "Higher dose requirements with insulin detemir in type 2 diabetes-three cases and a review of the literature" [Diab. Res. Clin. Pract. 84 (May (2)) (2009) e24-6 (Epub 2009 February 28)].

Davidson J, Koenen C. Davidson J, et al. Diabetes Res Clin Pract. 2009 Dec;86(3):e64-5. doi: 10.1016/j.diabres.2009.06.013. Epub 2009 Aug 11. Diabetes Res Clin Pract. 2009. PMID: 19674807 No abstract available.

2

A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial.

Heise T, Tack CJ, Cuddihy R, Davidson J, Gouet D, Liebl A, Romero E, Mersebach H, Dykiel P, Jorde R. Heise T, et al. Among authors: davidson j. Diabetes Care. 2011 Mar;34(3):669-74. doi: 10.2337/dc10-1905. Epub 2011 Feb 1. Diabetes Care. 2011. PMID: 21285389 Free PMC article. Clinical Trial.

3

Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes.

Bode B, Weinstein R, Bell D, McGill J, Nadeau D, Raskin P, Davidson J, Henry R, Huang WC, Reinhardt RR. Bode B, et al. Among authors: davidson j. Diabetes Care. 2002 Mar;25(3):439-44. doi: 10.2337/diacare.25.3.439. Diabetes Care. 2002. PMID: 11874927 Clinical Trial.

4

A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial.

Liebl A, Davidson J, Mersebach H, Dykiel P, Tack CJ, Heise T. Liebl A, et al. Among authors: davidson j. J Diabetes Sci Technol. 2013 Sep 1;7(5):1328-36. doi: 10.1177/193229681300700524. J Diabetes Sci Technol. 2013. PMID: 24124961 Free PMC article. Clinical Trial.

5

Initiating insulin in primary care--the role of modern premixed formulations.

Ligthelm R, Davidson J. Ligthelm R, et al. Among authors: davidson j. Prim Care Diabetes. 2008 Feb;2(1):9-16. doi: 10.1016/j.pcd.2008.01.005. Prim Care Diabetes. 2008. PMID: 18684415 Review.

6

Revised standards for the treatment of type 2 diabetes in Texas.

Davidson J. Davidson J. Diabetes Care. 1999 Jul;22(7):1219-20. doi: 10.2337/diacare.22.7.1219. Diabetes Care. 1999. PMID: 10388996 No abstract available.

7

Patients' perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study.

Cefalu WT, Mathieu C, Davidson J, Freemantle N, Gough S, Canovatchel W; OPTIMIZE Coalition. Cefalu WT, et al. Among authors: davidson j. Diabetes Technol Ther. 2008 Feb;10(1):25-38. doi: 10.1089/dia.2008.0249. Diabetes Technol Ther. 2008. PMID: 18275360

8

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R. Davidson J, et al. Clin Ther. 2005;27 Suppl B:S75-88. doi: 10.1016/j.clinthera.2005.11.022. Clin Ther. 2005. PMID: 16519039 Review.

9

Evaluation of diabetes patient-education programs.

Graber AL, Christman BG, Alogna MT, Davidson JK. Graber AL, et al. Among authors: davidson jk. Diabetes. 1977 Jan;26(1):61-4. doi: 10.2337/diab.26.1.61. Diabetes. 1977. PMID: 830566

10

Should postprandial glucose be measured and treated to a particular target? Yes.

Davidson J. Davidson J. Diabetes Care. 2003 Jun;26(6):1919-21. doi: 10.2337/diacare.26.6.1919. Diabetes Care. 2003. PMID: 12766134 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,631 results

Search Page

Filters